Prognosis of juvenile myoclonic epilepsy 45 years after onset: Seizure outcome and predictors

Neurology

Volumn 81, Issue 24, 2013, Pages 2128-2133

  Senf, Philine ^a   Schmitz, Bettina ^b   Holtkamp, Martin ^a   Janz, Dieter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b VIVANTES HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ABSENCE; ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MYOCLONUS EPILEPSY; ONSET AGE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCLONIC EPILEPSY, JUVENILE; PROGNOSIS; RETROSPECTIVE STUDIES; SEIZURES;

EID: 84892174073     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000437303.36064.f8     Document Type: Article

References (28)

1. Janz D, Christian W. Impulsiv - petit mal. J Neurol 1957; 176:346-386. Translated into English by Genton P. In: Malatosse A, Genton P, Hirsch E. Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. London: John Libbey; 1994:229-251.
2. Thomas P, Genton P, Gélisse P, Wolf P. Juvenile myoclonic epilepsy. In: Roger J, Buraeu M, Dravet CH, Genton P, Tassinari CA, Wolf P, editors. Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed. London: John Libbey; 2005:367-388.
3. Commission on Classification and Terminology of the International League Against Epilepsy (ILAE). Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
4. Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology 1984;34:285-294. (Pubitemid 14173203)
5. Christe W, Janz D. Valproate in idiopathic generalised epilepsies. Boll Lega Ital Epil 1988;61:11-15.
6. Martínez-Juárez IR, Alonso ME, Medina MT, et al. Juvenile myoclonic epilepsy subsyndromes: family studies and longterm follow-up. Brain 2006;129:1269-1280.
7. Noachtar S, Andermann E, Meyvisch P, et al. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008;70:607-616. (Pubitemid 351294638)
8. Morris GL, Hammer AE, Kustra RP, Messenheimer JA. Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study. Epilepsy Behav 2004;5:509-512. (Pubitemid 39060706)
9. Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin JJ, Legido A. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Epileptic Disord 2004;6:267-270. (Pubitemid 40095991)
10. Biton V, Bourgeois BF; YTC/YTCE Study Investigators. Topiramate in patients with juvenile myoclonic epilepsy. Arch Neurol 2005;62:1705-1708. (Pubitemid 41626666)
11. Janz D, Kern A, Mössinger HJ, Puhlmann U. Relapse prognosis following reduction of drugs in epilepsy treatment [in German]. Nervenarzt 1983;54:525-529. (Pubitemid 13016765)
12. Penry JK, Dean JC, Riela AR. Juvenile myoclonic epilepsy: long-term response to therapy. Epilepsia 1989;30:S19-S23. (Pubitemid 19247469)
13. Shinnar S, Berg AT, Moshé SL, et al. Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol 1994;35:534-545. (Pubitemid 24153836)
14. Panayiotopoulos CP, Obeid T, Tahan AR. JME: a 5-year prospective study. Epilepsia 1994;35:285-296.
15. Atakli D, Sözüer D, Atay T, Baybas S, Arpaci B. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 1998;7:63-66. (Pubitemid 28121952)
16. Sokic D, Ristic AJ, Vojvodic N, Jankovic S, Sindjelic AR. Frequency, causes and phenomenology of late seizure recurrence in patients with juvenile myoclonic epilepsy after a long period of remission. Seizure 2007;16:533-537. (Pubitemid 47213881)
17. Guaranha MS, Filho GM, Lin K, Guilhoto LM, Caboclo LO, Yacubian EM. Prognosis of juvenile myoclonic epilepsy is related to endophenotypes. Seizure 2011;20:42-48.
18. Calleja S, Salas-Puig J, Ribacoba R, Lahoz CH. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate. Seizure 2001;10:424-427. (Pubitemid 33114974)
19. Camfield CS, Camfield PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population based study. Neurology 2009;73:1041-1045.
20. Baykan B, Altindag EA, Bebek N, et al. Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy. Neurology 2008;70:2123-2129.
21. Geithner J, Schneider F, Wang Z, et al. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up. Epilepsia 2012;53:1379-1386.
22. Baykan B, Martinez-Juárez IE, Altindag EA, Camfield CS, Camfield PR. Lifetime prognosis of juvenile myoclonic epilepsy. Epilepsy Behav 2013;28(suppl 1):S18-S24.
23. Kasteleijn-Nolst Trenité DG, Schmitz B, Janz D, et al. Consensus on diagnosis and management of JME: from founder's observations to current trends. Epilepsy Behav 2013;28(suppl 1):S87-S90.
24. Gelisse P, Genton P, Thomas P, Rey M, Samuelian JC, Dravet C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 2001;70:240-243. (Pubitemid 32127866)
25. Jain S, Padma MV, Maheshwari MC. Occurrence of only myoclonic jerks in juvenile myoclonic epilepsy. Acta Neurol Scand 1997;95:263-267. (Pubitemid 27214474)
26. Panayiotopoulos CP, Obeid T, Waeed G. Differentiation of typical absence seizures in epileptic syndromes: a video EEG study of 224 seizures in 20 patients. Brain 1989;112: 1039-1056. (Pubitemid 19199483)
27. Jayalakshmi SS, Srinavasa Rao B, Sailaja S. Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy. Acta Neurol Scand 2010;122:115-123.
28. Gelisse P, Thomas P, Samuelian JC, Gentin P. Psychiatric disorders in juvenile myoclonic epilepsy. Epilepsia 2007; 48:1032-1033. (Pubitemid 46763397)